Why is Biocon falling/rising?

As of 01-Aug, Biocon Ltd. is experiencing a decline in its stock price, currently at 383.85, reflecting a decrease of 7.25 points or 1.85%. The stock has been on a downward trend, having fallen for the last three consecutive days, resulting in a total decline of 3.63% during this period. Despite outperforming its sector by 1.31% today, the stock's performance over the past week shows a decline of 2.58%, while it has generated a positive return of 5.93% over the past month. Positive factors such as a high inventory turnover ratio and significant growth in profit after tax contrast with negative aspects, including a high Debt to EBITDA ratio and a low return on equity, which may contribute to investor concerns and the stock's recent price movement.
In the broader market context, Biocon's recent performance has been relatively strong compared to the benchmark, as it has generated an 8.23% return over the past year, while the Sensex has declined by 1.55%. However, the pharmaceutical sector as a whole has faced challenges, with a sector decline of 3.26%. The overall market has also seen negative returns, with the BSE500 index down by 4.13% in the last year, indicating that while Biocon has outperformed its peers, the broader market conditions may still be impacting investor sentiment and participation, contributing to the stock's current decline.